$8.640
-0.327 (-3.79%)收盤時
ETRA 同業比較
In the context of the broader market, ETRA competes directly with industry leaders such as ACRS and DBVT. With a market capitalization of $548.68M, it holds a significant position in the sector. When comparing efficiency, ETRA's gross margin of N/A stands against ACRS's 10.80% and DBVT's N/A. Such benchmarking helps identify whether Electra Therapeutics, Inc. is trading at a premium or discount relative to its financial performance.
Electra Therapeutics, Inc. Common stock 財務表現
Electra Therapeutics has a price-to-book ratio of -21.688, indicating negative equity, and both its PE and forward PE ratios are 0, suggesting no earnings are currently being generated.
Financials
No data
本頁僅供研究參考，不構成投資建議。模型可能出錯。過往表現不代表未來結果。